Imaging of innate immunity activation in vivo with a redox-tuned PET reporter

High-redox-potential reactive oxygen species and reactive nitrogen species (ROS/RNS), generated by NADPH oxidase-2 (NOX2), myeloperoxidase (MPO) and related enzymes, are key effector molecules of innate immunity. High-redox-potential radicals are difficult to distinguish by imaging from less potent ROS/RNS functioning as background biological signaling molecules. Here we present 4-[F-18]fluoro-1-naphthol ([F-18]4FN), a redox-tuned radiopharmaceutical that selectively binds proteins and cells when oxidized by products of human MPO plus H2O2, but not H2O2 alone, and can be detected using positron emission tomography (PET). Activating HL-60 neutrophil-like human cells with phorbol ester (PMA) caused [F-18]4FN retention five-fold over unstimulated cells. An MPO-specific inhibitor (4-ABAH) blocked cellular retention by more than 95%. [F-18]4FN PET/CT imaging discriminated inflammatory foci in vivo in three murine models of activated innate immunity: endotoxin-induced toxic shock, PMA-induced contact dermatitis and lipopolysaccharide-induced ankle arthritis. 4-ABAH and Cybb(-/-) (Nox2(-/-)) gene deletion strongly abrogated [F-18]4FN retention in vivo. Thus, [F-18]4FN shows promise as a robust reporter of innate immunity activation by PET/CT. Inflammation is imaged in mice with a PET reporter of high-energy reactive oxygen and nitrogen species.

Automated summary

This study introduces a novel redox-tuned radiopharmaceutical called [F-18]4FN, which selectively binds proteins and cells oxidized by products of human MPO and H2O2, and can be detected using PET/CT technology. It shows promise as a robust reporter of activated innate immunity and has been successfully used to detect inflammation in mouse models.